HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Frank G Holz Selected Research

Macular Degeneration (Age-Related Maculopathy)

12/2015Omega-3 Fatty Acids and Age-Related Macular Degeneration.
12/2015Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study.
2/2015Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration.
1/2015Longitudinal analysis of reticular drusen associated with age-related macular degeneration using combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging.
5/2014Geographic atrophy: clinical features and potential therapeutic approaches.
3/2014Macular dystrophies mimicking age-related macular degeneration.
3/2014Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography.
2/2014The role of the complement system in age-related macular degeneration.
1/2014Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space.
10/2013Alterations of vascular pigment epithelium detachments associated with age-related macular degeneration during upload with intravitreal ranibizumab.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Frank G Holz Research Topics

Disease

44Macular Degeneration (Age-Related Maculopathy)
12/2015 - 02/2002
15Macular Edema
12/2015 - 11/2007
13Telangiectasis (Telangiectasia)
01/2016 - 01/2007
13Choroidal Neovascularization
10/2014 - 04/2002
12Retinal Diseases
10/2015 - 02/2002
11Geographic Atrophy
12/2015 - 02/2002
10Atrophy
01/2016 - 02/2002
8Diabetic Retinopathy (Retinopathy, Diabetic)
08/2015 - 09/2007
7Disease Progression
01/2015 - 01/2009
6Eye Diseases (Eye Disease)
01/2013 - 01/2006
4Cataract (Cataracts)
11/2014 - 10/2008
4Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome)
10/2011 - 12/2009
3Phototoxic Dermatitis (Phototoxicity)
12/2015 - 08/2015
3Angioid Streaks
07/2013 - 07/2011
3Photophobia (Light Sensitivity)
01/2010 - 08/2007
2Inflammation
01/2016 - 10/2015
2Choroid Diseases
10/2014 - 04/2002
2Carcinoma (Carcinomatosis)
11/2011 - 11/2005
2Retinal Detachment (Retinal Detachments)
02/2010 - 03/2004
1Retinal Degeneration
01/2016
1Endophthalmitis (Ophthalmia)
01/2016
1Retinal Vein Occlusion
01/2015
1Ganglion Cysts (Ganglion)
01/2015
1Retinoschisis (Retinoschisis, Juvenile)
12/2014
1Body Weight (Weight, Body)
10/2014
1Eye Pain
01/2014
1Spontaneous Abortion (Miscarriage)
01/2014
1Down Syndrome (Down's Syndrome)
01/2014
1Cysts
10/2013
1Hemorrhage
10/2013
1Scotoma (Scintillating Scotoma)
07/2013
1Gliosis
01/2013
1Cardiovascular Diseases (Cardiovascular Disease)
05/2012
1Neoplasm Metastasis (Metastasis)
11/2011
1Retinopathy of Prematurity (Retrolental Fibroplasia)
11/2011
1Fibrosis (Cirrhosis)
07/2011
1Glaucoma
04/2011
1Vitreous Hemorrhage
04/2011
1Retinal Hemorrhage
04/2011
1Hereditary Nephritis (Alport Syndrome)
03/2011
1Pain (Aches)
01/2011
1Vitelliform Macular Dystrophy
10/2010
1Central Serous Chorioretinopathy
08/2010
1Vision Disorders (Hemeralopia)
06/2010

Drug/Important Bio-Agent (IBA)

41Retinaldehyde (Retinal)IBA
01/2016 - 02/2002
16ranibizumab (Lucentis)FDA Link
01/2016 - 12/2007
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2015 - 11/2005
10LipofuscinIBA
12/2015 - 12/2002
8bevacizumabFDA Link
01/2016 - 01/2007
5Fluorescein (Funduscein)FDA LinkGeneric
01/2016 - 02/2003
4afliberceptIBA
10/2015 - 01/2014
3verteporfin (Visudyne)FDA Link
03/2015 - 12/2007
3Complement System Proteins (Complement)IBA
02/2014 - 01/2008
2salicylhydroxamic acid (SHAM)IBA
11/2014 - 04/2011
2Fluocinolone Acetonide (Capex)FDA LinkGeneric
10/2014 - 04/2011
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2014 - 04/2002
2Complement Factor H (Factor H)IBA
04/2012 - 01/2009
2Complement C3 (C3 Complement)IBA
04/2012 - 01/2009
21-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2008 - 12/2007
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
12/2015
1tandospironeIBA
12/2015
1leucyl-leucine-methyl esterIBA
10/2015
1leucylleucine (Leu-Leu)IBA
10/2015
1CytokinesIBA
10/2015
1Melanins (Melanin)IBA
01/2015
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2015
1tebufenozide (Mimic)IBA
03/2014
1Complement Factor D (Factor D)IBA
02/2014
1Glutaral (Glutaraldehyde)IBA
01/2014
1Formaldehyde (Formol)FDA Link
01/2014
1N-acetyltryptophanamide (NATA)IBA
10/2013
1LuteinIBA
05/2013
1zeaxanthinIBA
05/2013
1MicronutrientsIBA
01/2013
1Proteins (Proteins, Gene)IBA
01/2013
1Genetic Markers (Genetic Marker)IBA
05/2012
1Adenosine Triphosphate (ATP)IBA
04/2012
1LipidsIBA
11/2011
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2011
1GlycosaminoglycansIBA
03/2011
1Glutathione S-Transferase piIBA
12/2010
1Ketoconazole (Nizoral)FDA LinkGeneric
08/2010

Therapy/Procedure

21Lasers (Laser)
10/2015 - 02/2002
6Photochemotherapy (Photodynamic Therapy)
03/2015 - 02/2003
5Injections
01/2016 - 01/2010
4Intravitreal Injections
09/2013 - 02/2010
3Light Coagulation
10/2015 - 03/2012
3Lenses
11/2014 - 05/2013
2Transplantation (Transplant Recipients)
03/2014 - 01/2014
2Plasmapheresis
12/2010 - 05/2009
2Aftercare (After-Treatment)
06/2010 - 11/2005
1Sutures (Suture)
11/2014
1Intravenous Injections
10/2014
1Transplants (Transplant)
01/2014
1Retreatment
10/2013
1Vitrectomy
01/2013
1Intraocular Injections
05/2012
1Vitreoretinal Surgery
11/2011
1Intra-Arterial Injections
01/2011
1Traction
06/2010